Parallel Advisors’s Clearside Biomedical CLSD Stock Holding History

Parallel Advisors’s Portfolio CLSD Stock Details CLSD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-133	Closed	-$10K	–	3092
2021 Q2	$10K	Hold	133	–	–	﹤0.01%	1987
2021 Q1	$5K	Hold	133	–	–	﹤0.01%	2167
2020 Q4	$5K	Hold	133	–	–	﹤0.01%	2017
2020 Q3	$3K	Hold	133	–	–	﹤0.01%	2175
2020 Q2	$3K	Hold	133	–	–	﹤0.01%	2070
2020 Q1	$3K	Hold	133	–	–	﹤0.01%	2016
2019 Q4	$6K	Sell	133 -4,073	-97%	-$85.6K	﹤0.01%	1898
2019 Q3	$40K	Buy	4,206 +6	+0.1%	+$86	﹤0.01%	1074
2019 Q2	$61K	Hold	4,200	–	–	0.01%	837
2019 Q1	$87K	Buy	+4,200	New	+$83.3K	0.01%	654

Other funds holding CLSD

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

ACT Capital Management Wayne, Pennsylvania $127M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Two Sigma Advisers

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return